- Home
- CB vs SENS Comparison
CB vs SENS Comparison
Compare CB & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CB | SENS |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9B | 252.5M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | CB | SENS |
|---|---|---|
| Price | $311.86 | $6.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $309.65 | $25.58 |
| AVG Volume (30 Days) | ★ 1.9M | 355.7K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 23.94 | N/A |
| Revenue | ★ $58,842,000,000.00 | $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | $5.28 | $70.49 |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | 7.43 | ★ 31.94 |
| 52 Week Low | $252.16 | $5.25 |
| 52 Week High | $313.46 | $28.00 |
Technical Indicators
Market Signals| Indicator | CB | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 69.13 | 50.78 |
| Support Level | $308.50 | $6.02 |
| Resistance Level | $313.46 | $6.95 |
| Average True Range (ATR) | 4.86 | 0.39 |
| MACD | 1.14 | -0.10 |
| Stochastic Oscillator | 92.00 | 32.73 |
Price Performance
Historical ComparisonAbout CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.